Validation of the French Version RTWSE (Return To Work Self Efficacy Scale) (RTWSE)

October 31, 2019 updated by: University Hospital, Clermont-Ferrand

Validation of the French Version of the Questionnaires of Self-efficacy Received From the People With a Chronic Low Back Pain After Return to the Work (10 and 19 Items)

The back pain connected to the work stay a major problem in industrialized countries, in particular because of the repercussions of this affection on the work (sick leave, absenteeism, handicap and inaptitude). It is difficult to consider among all the patients with a Chronic Low Back Pain in the work: how much they are going to stop. However, Investigator can consider that approximately 20 % of the patients have a sick leave. Several studies showed well that more the sick leave work stoppage goes on more the risk of not resumption of work increases. Several risk factors were associated to the evolutionary forecast of the pathology and thus to the extension extra time of the sick leave: individual, environmental, psychosocial and organizational.

The evaluation of the self-efficiency perceived of return in the work of the patients by a validated auto-questionnaire is thus an additional objective parameter determining the risk factors of unfavorable evolution of the patients with Low Back Pain. This parameter also allows highlight other levers of actions in the therapeutic education.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

First stage: the translation of the RTWSE in French followed the recommendations of the literature, which recommend a double translation, then a double back - translation with synthesis of the data in every stage. A final commission deliberate then a final translation, culturally adapted.

The second stage: the RTWSE is given to the patients with a Chronic Back Pain in the program of functional restoration of the rachis. Questionnaire FABQ, BARBECUE and Quebec are also given to the patient to obtain the status "faith" and the "functional" status. The questionnaire JDI as well as the analog visual scale is given to estimate the global professional satisfaction. The pain is estimated by a digital scale. The score IPAQ allows to estimate the level of physical activity of the patients. The HAD allows to estimate the level of anxiety and depression of the patients.

The additional questionnaires used for several reasons: in routine for the evaluation of the patients with a Chronic Back Pain; to characterize the patients and within the framework of the study for the validity of convergence and difference of questionnaires RTWSE 10 and 19 items.

The third stage: the questionnaire RTWSE is given again to the patient at 72 hours interval while the state of the patient is considered as stable.

The fourth stage: the questionnaires are given at J21 and in 2 months apart for the study of the sensibility in the change with the FABQ, BARBECUE, Quebec and the IPAQ.

Study Type

Observational

Enrollment (Actual)

70

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Clermont-Ferrand, France, 63003
        • CHU clermont-ferrand

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients with a chronic back pain

Description

Inclusion Criteria:

  • Both sexes
  • Adult (>18 years old)
  • Chronic Low Back Pain evolving for at least 3 months
  • Acceptance to participate in the study
  • Patients affiliated to a social security scheme (beneficiary entitled)

Exclusion Criteria:

  • Patient under guardianship, or protection of justice.
  • Patient in the incapacity to answer the questionnaire.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
patient with a chronic back pain
The evaluation of the self-efficiency perceived of return in the work of the patients by a validated auto-questionnaire is thus an additional objective parameter determining the risk factors of unfavorable evolution of the patients with Low Back Pain. This parameter also allows highlight other levers of actions in the therapeutic education.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Psychometric properties of the questionnaires RTWSE (Return To Work Self Efficacy Scale, 10 et 19 items)
Time Frame: at 0 day
at 0 day
Psychometric properties of the questionnaires RTWSE (Return To Work Self Efficacy Scale, 10 et 19 items)
Time Frame: at 3 days
at 3 days
Psychometric properties of the questionnaires RTWSE (Return To Work Self Efficacy Scale, 10 et 19 items)
Time Frame: at 21 days
at 21 days
Psychometric properties of the questionnaires RTWSE (Return To Work Self Efficacy Scale, 10 et 19 items)
Time Frame: at 2 months
at 2 months

Secondary Outcome Measures

Outcome Measure
Time Frame
The fears and the faiths measured by questionnaire FABQ
Time Frame: at day 0
at day 0
The fears and the faiths measured by questionnaire FABQ
Time Frame: at 21 days
at 21 days
The fears and the faiths measured by questionnaire FABQ
Time Frame: at 2 months
at 2 months
Average change from baselin in the pain intensity measured on a Visual Analogical Scale (VAS)
Time Frame: at day 0
at day 0
Average change from baselin in the pain intensity measured on a Visual Analogical Scale (VAS)
Time Frame: at day 3
at day 3
Average change from baselin in the pain intensity measured on a Visual Analogical Scale (VAS)
Time Frame: at day 21
at day 21
Average change from baselin in the pain intensity measured on a Visual Analogical Scale (VAS)
Time Frame: at 2 months
at 2 months
Level of physical activity measured by short questionnaire IPAQ
Time Frame: at day 0
at day 0
Level of physical activity measured by short questionnaire IPAQ
Time Frame: at 2 months
at 2 months
The 14-item Beliefs and Behaviors Questionnaire (BBQ) measures beliefs, experiences and adherent behavior related with Low Back pain
Time Frame: at day 0
at day 0
The 14-item Beliefs and Behaviors Questionnaire (BBQ) measures beliefs, experiences and adherent behavior related with Low Back pain
Time Frame: at 3 days
at 3 days
The 14-item Beliefs and Behaviors Questionnaire (BBQ) measures beliefs, experiences and adherent behavior related with Low Back pain
Time Frame: at 2 months
at 2 months
The knowledge of emotional state measured by questionnaire HAD
Time Frame: at day 0
at day 0
The knowledge of emotional state measured by questionnaire HAD
Time Frame: at 21 days
at 21 days
Self-assessment of the incapacity, that deals with the echo on the everyday life measured by questionnaire QUEBEC
Time Frame: at day 0
at day 0
Self-assessment of the incapacity, that deals with the echo on the everyday life measured by questionnaire QUEBEC
Time Frame: at 21 days
at 21 days
Self-assessment of the incapacity, that deals with the echo on the everyday life measured by questionnaire QUEBEC
Time Frame: at 2 months
at 2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

April 1, 2016

Primary Completion (ACTUAL)

December 1, 2017

Study Completion (ACTUAL)

July 30, 2018

Study Registration Dates

First Submitted

March 20, 2017

First Submitted That Met QC Criteria

March 23, 2017

First Posted (ACTUAL)

March 24, 2017

Study Record Updates

Last Update Posted (ACTUAL)

November 1, 2019

Last Update Submitted That Met QC Criteria

October 31, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CHU-309

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Low Back Pain

Clinical Trials on questionnaire RTWSE

Subscribe